Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

29 trials with published results (19%)

Research Maturity

92 completed trials (61% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.2%

11 terminated out of 152 trials

Success Rate

89.3%

+2.7% vs benchmark

Late-Stage Pipeline

13%

19 trials in Phase 3/4

Results Transparency

32%

29 of 92 completed with results

Key Signals

29 with results89% success11 terminated

Data Visualizations

Phase Distribution

90Total
Not Applicable (48)
Early P 1 (1)
P 1 (13)
P 2 (9)
P 3 (5)
P 4 (14)

Trial Status

Completed92
Recruiting20
Unknown17
Terminated11
Withdrawn4
Active Not Recruiting3

Trial Success Rate

89.3%

Benchmark: 86.6%

Based on 92 completed trials

Clinical Trials (152)

Showing 20 of 20 trials
NCT01143454Recruiting

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

NCT07116525Not ApplicableRecruiting

A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter

NCT07479641Phase 1CompletedPrimary

A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants

NCT07738107Phase 1Recruiting

ATR 1072 in Participants With PRKAG2 Syndrome

NCT06896266Recruiting

Genetic Characterization of Patients With Arrhythmia-Induced Cardiomyopathy

NCT06865482Recruiting

Clinical Course Of Disease In Participants With FA-CM

NCT05112237Active Not RecruitingPrimary

Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

NCT06800716Recruiting

Impella Reverse Remodeling in End-Stage Heart Failure

NCT05371496Phase 4CompletedPrimary

Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction

NCT07753135Active Not Recruiting

Association of Heart Failure Aggravation and Device-based Sensor Parameters

NCT05507879Recruiting

TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer

NCT02962661Phase 1SuspendedPrimary

Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

NCT07674758Recruiting

Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials

NCT07617844Recruiting

Multimodal mAgnetic Resonance imaGIng in Cardiovascular Disease

NCT07541833RecruitingPrimary

Effectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan (MANAGE-HCM)

NCT07591038Not Yet Recruiting

PET/CT Imaging in Carriers of TTR Mutations

NCT07574697RecruitingPrimary

AIC Genotyping Study

NCT03057561Not ApplicableCompleted

Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance

NCT01143519Completed

Study of the Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage

NCT07308704RecruitingPrimary

A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation

Scroll to load more

Research Network

Activity Timeline